Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +142.7%

Quarter to September 2026, against a year earlier

110.08 3.52 −3.10%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 42.3×
Fwd P/E: 35.1×
Dividend yield: 2.22%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	0.00%	10.58%	12.33%	12.96%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	—	4	4	5
ROA Full definition →	0.00%	5.62%	6.54%	7.76%
ROIC Full definition →	0.00%	5.83%	6.06%	8.87%
Return on Tangible Assets Full definition →	0.00%	27.80%	32.17%	30.61%
Average Days of Receivables Full definition →	0.00	67.37	66.39	65.29
Free Cash Flow per Share Full definition →	—	4.50	4.23	4.25
Free Cash Flow Full definition →	—	7,824.00	7,378.00	7,395.00
Capital Expenditures Full definition →	—	(2,081.00)	(2,086.00)	(2,171.00)
Other line items
Cash ROIC Full definition →	—	8.70%	7.85%	9.91%
Accounts Receivable Turnover Full definition →	0.00	5.62	5.81	5.97
Accounts Payable Turnover Full definition →	0.00	4.44	4.44	4.58
Inventory Turnover Full definition →	0.00	2.83	2.90	3.05
Average Days of Payables Full definition →	0.00	86.57	86.51	80.11
Days of Inventory on Hand Full definition →	0.00	132.10	129.22	122.58
Tax Rate Full definition →	(0.28)	(0.28)	(0.23)	(0.23)
Research and Development Expense of Revenue Full definition →	6.87%	6.78%	6.63%	6.64%
Selling, General and Administrative Expense of Revenue Full definition →	31.43%	29.93%	28.83%	27.82%
Share Based Compensation of Revenue Full definition →	0.00%	1.54%	1.53%	1.50%
Interest Coverage Full definition →	7.06	9.59	14.38	16.33
Operating CF/Net income Full definition →	0.00	1.83	1.51	1.47
Depreciation/Fixed assets Full definition →	—	0.27	0.26	0.26
Capex/Depreciation Full definition →	—	(0.60)	(0.66)	(0.70)
Revenue per Share Full definition →	0.00	26.77	25.90	25.46
Operating CF per Share Full definition →	—	5.69	5.43	5.49
Capex per Share Full definition →	—	(1.20)	(1.20)	(1.25)
Capex to Sales Full definition →	0.00	0.04	0.05	0.05

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly